5-Aminolaevulinic Acid (ala) Induces Permanent Acceptance of Mouse Cardiac Allograft by Increasing Regulatory T Cells

J. Hou,Q. Zhang,S. Cai,K. Takahashi,F. Abe,S. -I. Ogura,J. Xu,Q. Ding,X. -K. Li

DOI: https://doi.org/10.1097/00007890-201211271-02222

2012-01-01

Transplantation

Abstract:5-aminolevulinic acid (ALA), an intermediate in heme synthesis is fundamentally important in aerobic energy metabolism. HO activity cleaves heme to form biliverdin, CO, and iron (Fe2+). Carbon monoxide (CO), or bilirubin administration to, donors and/or recipients frequently lead to long-term survival of islet allografts. The anti-inflammatory properties of biliverdin and CO provide us with potential novel means in a broad spectrum of graft injury experimental models, including ischemia/reperfusion, acute and/or chronic allograft rejection. The purpose of this study is to test the hypothesis that administration of ALA has a salutary effect in organ transplantation. The high level of CO concentration was detected after ALA and Fe2+ administration. A brief course of treatment with ALA lead to permanent acceptance (>100 days, n=13) in mouse heart allografts, are dose and Fe2+ dependently. In consistent with graft survival, we found that the graft infiltration cells were fewer and the responses of the recipient spleen T cells to donor type alloantigen stimulation in mixed lymphocyte reaction assay was lower than that of the control group recipients. In addition, with the administration of ALA and Fe2+, Foxp3+ Treg cells were significantly increased after transplantation. Hence our data indicated that ALA and Fe2+ treatment impaired T cells proliferate in response to alloantigens and increased Treg cell, result in permanent acceptance in mouse cardiac allografts. This finding also has important implications for clarifying the mechanism of CO and/or HO-1 activity in tolerance induction, may be effective for treatment of allograft rejection clinically in the near future.